Articles by Disease (Melanoma)

From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9
Page: 221-229
Author(s): Isabelle Dussault and Steven F. Bellon

The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy

Journal: Current Cancer Drug Targets
Volume: 9
Page: 32-71
Author(s): Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti and Massimino D'Armiento

The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunates Activity in Cancer Cells

Journal: Current Cancer Drug Targets
Volume: 9
Page: 72-80
Author(s): V. Badireenath Konkimalla, James A. McCubrey and Thomas Efferth

Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy

Journal: Current Cancer Drug Targets
Volume: 9
Page: 101-117
Author(s): Paul R. Andreassen and Keqin Ren

Monocyte Dependent Regulation of Autoimmune Inflammation

Journal: Current Molecular Medicine
Volume: 9
Page: 23-29
Author(s): Lindsay B. Nicholson, Ben J.E. Raveney and Markus Munder

Anti-angiogenic Drugs as an Adjunctive Therapy in the Surgical Treatment of Diabetic Retinopathy

Journal: Current Diabetes Reviews
Volume: 5
Page: 52-56
Author(s): Marta S. Figueroa, Ines Contreras and Susana Noval

Nanoparticulate Iron Oxide Contrast Agents for Untargeted and Targeted Cardiovascular Magnetic Resonance Imaging

Journal: Current Nanoscience
Volume: 5
Page: 88-102
Author(s): A. Jasper Nijdam, Theodore R. Nicholson III, John P. Shapiro, Bryan R. Smith, Johannes T. Heverhagen, Petra Schmalbrock, Michael V. Knopp, Andrew Kebbel, David Wang and Stephen C. Lee